Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Scientific Reports
|
July 8, 2023
Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study
Sevinj Yolchuyeva, Elena Giacomazzi, Marion Tonneau, et al.
JTO Clinical and Research Reports
|
December 21, 2023
Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study
Sevinj Yolchuyeva, Elena Giacomazzi, Marion Tonneau, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 11, 2023
A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy
Marion Tonneau, Corentin Richard, Bertrand Routy, et al.
Cancer Treatment and Research Communications
|
October 13, 2023
The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy
Francis Proulx-Rocray, Bertrand Routy, Rami Nassabein, et al.
Cancers
|
February 24, 2024
CXCL13 Positive Cells Localization Predict Response to Anti-PD-1/PD-L1 in Pulmonary Non-Small Cell Carcinoma
Fatemeh Vahidian, Fabien C Lamaze, Cédrik Bouffard, et al.
Cancers
|
August 12, 2023
A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study
Sevinj Yolchuyeva, Elena Giacomazzi, Marion Tonneau, et al.
Cancers
|
January 23, 2024
The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary Study
Abdou Khadir Dia, Leyla Ebrahimpour, Sevinj Yolchuyeva, et al.
Clinical and Translational Radiation Oncology
|
March 4, 2022
<b>S</b>tereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC)
Houda Bahig, Marion Tonneau, Normand Blais, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
November 12, 2025
Radiotherapy for lung metastases
Antonin Levy, Marion Tonneau, Julien Darréon, et al.
Journal of Translational Medicine
|
May 6, 2025
Computational analysis of whole slide images predicts PD-L1 expression and progression-free survival in immunotherapy-treated non-small cell lung cancer patients
Abdou Khadir Dia, Alona Kolnohuz, Sevinj Yolchuyeva, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Scientific Reports
|
July 8, 2023
Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study
Sevinj Yolchuyeva, Elena Giacomazzi, Marion Tonneau, et al.
JTO Clinical and Research Reports
|
December 21, 2023
Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study
Sevinj Yolchuyeva, Elena Giacomazzi, Marion Tonneau, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 11, 2023
A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy
Marion Tonneau, Corentin Richard, Bertrand Routy, et al.
Cancer Treatment and Research Communications
|
October 13, 2023
The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy
Francis Proulx-Rocray, Bertrand Routy, Rami Nassabein, et al.
Cancers
|
February 24, 2024
CXCL13 Positive Cells Localization Predict Response to Anti-PD-1/PD-L1 in Pulmonary Non-Small Cell Carcinoma
Fatemeh Vahidian, Fabien C Lamaze, Cédrik Bouffard, et al.
Cancers
|
August 12, 2023
A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study
Sevinj Yolchuyeva, Elena Giacomazzi, Marion Tonneau, et al.
Cancers
|
January 23, 2024
The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary Study
Abdou Khadir Dia, Leyla Ebrahimpour, Sevinj Yolchuyeva, et al.
Clinical and Translational Radiation Oncology
|
March 4, 2022
<b>S</b>tereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC)
Houda Bahig, Marion Tonneau, Normand Blais, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
November 12, 2025
Radiotherapy for lung metastases
Antonin Levy, Marion Tonneau, Julien Darréon, et al.
Journal of Translational Medicine
|
May 6, 2025
Computational analysis of whole slide images predicts PD-L1 expression and progression-free survival in immunotherapy-treated non-small cell lung cancer patients
Abdou Khadir Dia, Alona Kolnohuz, Sevinj Yolchuyeva, et al.
Page
of 3